Conclusion: Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
Does Modafinil help with focus?
Yes, for most people. 86% of 689 people who reported on Modafinil for focus say it improved. 10% noticed no change and 4% say it got worse. That is about the typical result for focus (86% across 80 options).
Across all 929 first-hand reports on Modafinil (any goal): worked for 50%, worked with downsides for 35%, did not work for 15%. Most reported side effects: insomnia, anxiety, headache, tolerance.
Ranked #16 of 80 for focus.
People it helped with focus
“The only med that works for my ADHD plus very little side effects.”
“You may like it better, it doesn't give you the jitters but it gives you all the focus and energy. At least that's my experience.”
“Modafinil(200mg) makes me so outgoing and extroverted. It gives me soo much energy and the just do it attitude.”
“I'm currently using modafinil and it's the only thing that thoroughly treats my depression and anhedonia, brain fog and actually makes me feel alive.”
Problems people report with Modafinil
“Modafinil does nothing for me when I'm rested, except a headache in larger doses. It works the way it's supposed to - it keeps me alert when I'm tired, and miraculously, there's no sleep debt afterwards.”
What the research says
Conclusion: Overall, despite a class effect of improving clinical response relative to placebo, there were few differences among the individual ADHD pharmacotherapies, and most studies were at risk of at least one important source of bias. Furthermore, the certainty of the evidence was very low to low for all outcomes, and there was limited reporting of long-term adverse events. As such, the choice between ADHD pharmacotherapies may depend on individual patient considerations, and future studies should assess the long-term effects of individual pharmacotherapies on patient-important outcomes, including qu
Side effects people mention
What else is Modafinil used for?
Information only — not medical advice. How we count